Dian Kang

438 total citations
26 papers, 370 citations indexed

About

Dian Kang is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Dian Kang has authored 26 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Complementary and alternative medicine. Recurrent topics in Dian Kang's work include Ginseng Biological Effects and Applications (7 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Traditional Chinese Medicine Analysis (5 papers). Dian Kang is often cited by papers focused on Ginseng Biological Effects and Applications (7 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Traditional Chinese Medicine Analysis (5 papers). Dian Kang collaborates with scholars based in China and United States. Dian Kang's co-authors include Yan Liang, Guangji Wang, Lin Xie, Haofeng Li, Tai Rao, Xinuo Li, Yangfan Xu, Huimin Chen, Jiajia Shen and Wei Ye and has published in prestigious journals such as Cancer Research, Analytica Chimica Acta and Journal of Ethnopharmacology.

In The Last Decade

Dian Kang

26 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dian Kang China 13 251 93 60 54 26 26 370
Robert‐Jan A. N. Lamers Netherlands 10 361 1.4× 68 0.7× 115 1.9× 82 1.5× 42 1.6× 12 569
Ran Liu China 13 243 1.0× 53 0.6× 45 0.8× 44 0.8× 29 1.1× 33 417
Yingyuan Lu China 12 187 0.7× 68 0.7× 68 1.1× 10 0.2× 34 1.3× 48 362
Wan-Lin Chang China 11 152 0.6× 45 0.5× 54 0.9× 11 0.2× 32 1.2× 17 361
Jihong Chu China 9 197 0.8× 43 0.5× 102 1.7× 12 0.2× 37 1.4× 17 369
Wenfeng Xin China 9 209 0.8× 57 0.6× 128 2.1× 22 0.4× 60 2.3× 20 411
Youli Lu China 11 136 0.5× 39 0.4× 84 1.4× 31 0.6× 16 0.6× 23 335
Lihui Men China 11 269 1.1× 71 0.8× 55 0.9× 8 0.1× 35 1.3× 25 403
Tianwei Dong China 6 251 1.0× 56 0.6× 89 1.5× 39 0.7× 20 0.8× 10 376

Countries citing papers authored by Dian Kang

Since Specialization
Citations

This map shows the geographic impact of Dian Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dian Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dian Kang more than expected).

Fields of papers citing papers by Dian Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dian Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dian Kang. The network helps show where Dian Kang may publish in the future.

Co-authorship network of co-authors of Dian Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Dian Kang. A scholar is included among the top collaborators of Dian Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dian Kang. Dian Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, He, Chuanfei Yu, Wanqiu Huang, et al.. (2023). Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305. PubMed. 6(3). 194–210. 1 indexed citations
2.
Yan, Caixia, Huimin Guo, Qingqing Ding, et al.. (2020). Multiomics Profiling Reveals Protective Function of Schisandra Lignans against Acetaminophen-Induced Hepatotoxicity. Drug Metabolism and Disposition. 48(10). 1092–1103. 13 indexed citations
3.
Shen, Jiajia, Dawei Wang, Chong Chen, et al.. (2019). An auxiliary matrix for routine analysis of small molecules and biological macromolecules using matrix-assisted laser desorption ionization mass spectrometry. Analytical and Bioanalytical Chemistry. 411(5). 1041–1052. 10 indexed citations
4.
Kang, Dian, Qingqing Ding, Yangfan Xu, et al.. (2019). Comparative analysis of constitutes and metabolites for traditional Chinese medicine using IDA and SWATH data acquisition modes on LC-Q-TOF MS. Journal of Pharmaceutical Analysis. 10(6). 588–596. 25 indexed citations
5.
Kang, Dian, Chong Chen, Yangfan Xu, et al.. (2018). Systematically identifying the hepatoprotective ingredients of schisandra lignan extract from pharmacokinetic and pharmacodynamic perspectives. Phytomedicine. 53. 182–192. 21 indexed citations
6.
Li, Xinuo, Dian Kang, Haofeng Li, et al.. (2018). Activated charcoal significantly improved the reliability of methods for quantitative analysis of endogenous substances in biological specimens: Glutathione and cysteine as cases. Journal of Chromatography B. 1095. 241–250. 13 indexed citations
7.
Chen, Huimin, Jiajia Shen, Haofeng Li, et al.. (2018). Ginsenoside Rb1 exerts neuroprotective effects through regulation of Lactobacillus helveticus abundance and GABAA receptor expression. Journal of Ginseng Research. 44(1). 86–95. 37 indexed citations
8.
Chen, Chong, Yangfan Xu, Jiajia Shen, et al.. (2018). Is the combinational administration of doxorubicin and glutathione a reasonable proposal?. Acta Pharmacologica Sinica. 40(5). 699–709. 22 indexed citations
9.
Rao, Tai, Yangfan Xu, Dian Kang, et al.. (2017). Pharmacokinetic and pharmacodynamic evidence for developing an oral formulation of octreotide against gastric mucosal injury. Acta Pharmacologica Sinica. 39(8). 1373–1385. 8 indexed citations
10.
Li, Haofeng, Xinuo Li, Huimin Chen, et al.. (2017). Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides. Drug Metabolism and Disposition. 46(1). 53–65. 24 indexed citations
11.
Wang, Guangji, Wei Ye, Xiao Zheng, et al.. (2016). Comprehensive characterization of the in vitro and in vivo metabolites of ziyuglycoside I in rat microsome, intestinal flora, excretion specimen and fresh tissues based on LC–Q-TOF/MS. Journal of Pharmaceutical and Biomedical Analysis. 128. 191–200. 26 indexed citations
12.
13.
14.
Chen, Huimin, Wei Ye, Tai Rao, et al.. (2016). Development of a novel sectional multiple filtering scheme for rapid screening and classifying metabolites of ziyuglycoside II in rat liver and excreta specimen based on high-resolution mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 129. 310–319. 11 indexed citations
15.
Wang, Guangji, Qian Wang, Tai Rao, et al.. (2016). A robust LC–MS/MS method for the determination of pidotimod in different biological matrixes and its application to in vivo and in vitro pharmacokinetic studies. Journal of Chromatography B. 1023-1024. 36–43. 1 indexed citations
16.
Rao, Tai, Dian Kang, Xinuo Li, et al.. (2016). Optimization and evaluation of MALDI TOF mass spectrometric imaging for quantification of orally dosed octreotide in mouse tissues. Talanta. 165. 128–135. 13 indexed citations
17.
Wang, Guangji, Ye Wei, Tai Rao, et al.. (2016). Appropriate choice of collision-induced dissociation energy for qualitative analysis of notoginsenosides based on liquid chromatography hybrid ion trap time-of-flight mass spectrometry. Chinese Journal of Natural Medicines. 14(4). 278–285. 4 indexed citations
18.
Chen, Huimin, Dian Kang, Xinuo Li, et al.. (2016). Qualitatively and quantitatively investigating the regulation of intestinal microbiota on the metabolism of panax notoginseng saponins. Journal of Ethnopharmacology. 194. 324–336. 48 indexed citations
19.
20.
Kang, Dian. (2001). Epidemiological Changes of Hemorrhage Fever with Renal Syndrome in Shandong Province,1990～1998. China Public Health. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert‐Jan A. N. Lamers Breakdown of academic impact, for papers by Ran Liu Breakdown of academic impact, for papers by Yingyuan Lu Breakdown of academic impact, for papers by Wan-Lin Chang Breakdown of academic impact, for papers by Jihong Chu Breakdown of academic impact, for papers by Wenfeng Xin Breakdown of academic impact, for papers by Youli Lu Breakdown of academic impact, for papers by Lihui Men Breakdown of academic impact, for papers by Tianwei Dong
Rankless by CCL
2026